Related references
Note: Only part of the references are listed.Garlic (Allium sativum L.): Its Chemistry, Nutritional Composition, Toxicity, and Anticancer Properties
Abdur Rauf et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2022)
Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer
RamaRao Malla et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2022)
Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
Anuhya Kommalapati et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer
Daniel J. Schaid et al.
EUROPEAN UROLOGY (2021)
The epigenetic basis of cellular heterogeneity
Benjamin Carter et al.
NATURE REVIEWS GENETICS (2021)
Staying true to yourself: mechanisms of DNA methylation maintenance in mammals
Nataliya Petryk et al.
NUCLEIC ACIDS RESEARCH (2021)
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Daniele Tavernari et al.
CANCER DISCOVERY (2021)
Nuclear mechanisms of gene expression control: pre-mRNA splicing as a life or death decision
Jackson M. Gordon et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2021)
Tracking Cancer Evolution through the Disease Course
Chris Bailey et al.
CANCER DISCOVERY (2021)
S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling
Pingping Luo et al.
ACTA PHARMACEUTICA SINICA B (2021)
UHRF1 regulates alternative splicing by interacting with splicing factors and U snRNAs in a H3R2me involved manner
Peng Xu et al.
HUMAN MOLECULAR GENETICS (2021)
NucHMM: a method for quantitative modeling of nucleosome organization identifying functional nucleosome states distinctly associated with splicing potentiality
Kun Fang et al.
GENOME BIOLOGY (2021)
Genetic and non-genetic clonal diversity in cancer evolution
James R. M. Black et al.
NATURE REVIEWS CANCER (2021)
Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
Xi Chen et al.
ACTA PHARMACEUTICA SINICA B (2020)
Genomic basis for RNA alterations in cancer
Claudia Calabrese et al.
NATURE (2020)
Zinc Finger Transcription Factor MZF1-A Specific Regulator of Cancer Invasion
Ditte Marie Brix et al.
CELLS (2020)
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates
Silvia Belluti et al.
CELLS (2020)
Roles and mechanisms of alternative splicing in cancer - implications for care
Sophie C. Bonnal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Specific histone modifications associate with alternative exon selection during mammalian development
Qiwen Hu et al.
NUCLEIC ACIDS RESEARCH (2020)
Transcription of intragenic CpG islands influences spatiotemporal host gene pre-mRNA processing
Samuele M. Amante et al.
NUCLEIC ACIDS RESEARCH (2020)
Alternative splicing and allosteric regulation modulate the chromatin binding of UHRF1
Maria Tauber et al.
NUCLEIC ACIDS RESEARCH (2020)
A role for LSH in facilitating DNA methylation by DNMT1 through enhancing UHRF1 chromatin association
Mengmeng Han et al.
NUCLEIC ACIDS RESEARCH (2020)
Proteomic Analysis of Azacitidine-Induced Degradation Profiles Identifies Multiple Chromatin and Epigenetic Regulators Including Uhrf1 and Dnmt1 as Sensitive to Azacitidine
Emily H. Bowler et al.
JOURNAL OF PROTEOME RESEARCH (2019)
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
Honghai Ma et al.
SCIENTIFIC REPORTS (2019)
coMethDMR: accurate identification of co-methylated and differentially methylated regions in epigenome-wide association studies with continuous phenotypes
Lissette Gomez et al.
NUCLEIC ACIDS RESEARCH (2019)
Sensitivity of transcription factors to DNA methylation
Elea Heberle et al.
DNA METHYLATION (2019)
Non-Genetic Intra-Tumor Heterogeneity Is a Major Predictor of Phenotypic Heterogeneity and Ongoing Evolutionary Dynamics in Lung Tumors
Anchal Sharma et al.
CELL REPORTS (2019)
Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A
Shuye Lin et al.
CLINICAL CANCER RESEARCH (2019)
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
Vitor H. Teixeira et al.
NATURE MEDICINE (2019)
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Ferdinandos Skoulidis et al.
NATURE REVIEWS CANCER (2019)
Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
Dorothea M. Heuberger et al.
THROMBOSIS JOURNAL (2019)
Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway
Jia Xiao et al.
ACTA PHARMACEUTICA SINICA B (2018)
Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger–containing 1 (UHRF1) for anti-cancer drug development
Debasis Patnaik et al.
Oncotarget (2018)
Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma
Eric Hervouet et al.
CLINICAL EPIGENETICS (2018)
Genetic and transcriptional evolution alters cancer cell line drug response
Uri Ben-David et al.
NATURE (2018)
Terminal exon characterization with TECtool reveals an abundance of cell-specific isoforms
Andreas J. Gruber et al.
NATURE METHODS (2018)
Stella safeguards the oocyte methylome by preventing de novo methylation mediated by DNMT1
Yingfeng Li et al.
NATURE (2018)
Splicing heterogeneity: separating signal from noise
Yihan Wan et al.
GENOME BIOLOGY (2018)
The Ubiquitin-like with PHD and Ring Finger Domains 1 (UHRF1)/DNA Methyltransferase 1 (DNMT1) Axis Is a Primary Regulator of Cell Senescence
Hyun-Jung Jung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma
Bonan Lin et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Intragenic DNA methylation prevents spurious transcription initiation
Francesco Neri et al.
NATURE (2017)
DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease
Danuta M. Jeziorska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
FirebrowseR: an R client to the Broad Institute's Firehose Pipeline
Mario Deng et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2017)
Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease
Magnus Tobiasson et al.
ONCOTARGET (2017)
The Functional Impact of Alternative Splicing in Cancer
Hector Climente-Gonzalez et al.
CELL REPORTS (2017)
Role of UHRF1 in de novo DNA methylation in oocytes and maintenance methylation in preimplantation embryos
Shoji Maenohara et al.
PLOS GENETICS (2017)
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
Michael J. Topper et al.
CELL (2017)
Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-B Activation
Yuanming Pan et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
Mahmoud Alhosin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2
Carmen Ghilardi et al.
ONCOTARGET (2015)
Non-small-cell lung cancers: a heterogeneous set of diseases
Zhao Chen et al.
NATURE REVIEWS CANCER (2014)
DNA methylation presents distinct binding sites for human transcription factors
Shaohui Hu et al.
ELIFE (2013)
PRSS3/Mesotrypsin Is a Therapeutic Target for Metastatic Prostate Cancer
Alexandra Hockla et al.
MOLECULAR CANCER RESEARCH (2012)
Consumption of Large Amounts of Allium Vegetables Reduces Risk for Gastric Cancer in a Meta-analysis
Yong Zhou et al.
GASTROENTEROLOGY (2011)
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
Rosalyn A. Juergens et al.
CANCER DISCOVERY (2011)
Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109
Alexandra Hockla et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
PRSS3 promotes tumour growth and metastasis of human pancreatic cancer
Guozhong Jiang et al.
GUT (2010)
The Amyloid Precursor Protein/Protease Nexin 2 Kunitz Inhibitor Domain Is a Highly Specific Substrate of Mesotrypsin
Moh'd A. Salameh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Tumour micro environment -: Opinion -: Emerging roles of proteases in tumour suppression
Carlos LOpez-Otin et al.
NATURE REVIEWS CANCER (2007)
Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia
Wolfgang Knecht et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer
Carmen J. Marsit et al.
CARCINOGENESIS (2007)
Carcinogen exposure and gene promoter hypermethylation in bladder cancer
CJ Marsit et al.
CARCINOGENESIS (2006)
Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer
CJ Marsit et al.
MOLECULAR CARCINOGENESIS (2005)
S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer
S Diederichs et al.
CANCER RESEARCH (2004)
Protease-activated receptor 2 in colon cancer - Trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation
D Darmoul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
